NanoRepro aims to create a constantly and consistently growing value for its clients, shareholders and employees. This is why we develop innovative products of the highest quality and offer our services in the fields of health care and precaution. In the medium term, NanoRepro aspires to reach European market leadership in these fields, while in the long-term, the company aims to become the leading global player.
For years the markets in which we are active have shown a constant increase of demand. External analyses predict a further strong growth of these markets. For instance the German market for ovulation tests is increasing by about 30% each year. The following factors explain the consistent growth of the market for rapid diagnostic tests (OTC):
- Time and cost: OTC rapid diagnostic tests are significantly less time-consuming and costly than comparable tests at a doctor’s surgery
- Discretion: OTC rapid diagnostic tests provide greater discretion, especially important for tests concerned with intimate areas of life
- Health awareness: increasing health awareness among the population has been a major factor in stimulating demand for rapid home tests
NanoRepro’s strong and experienced management and shareholder team ensures innovation strength, product quality and delivery reliability. In order to meet the high demands for quality our scientists cooperate with institutions like the Fraunhofer Institute or TU Munich. In terms of production, the company has a strong and exclusive strategic partnership with a highly experienced and efficient German contract manufacturer specialising in the field of rapid diagnostic tests.
With regard to product design and marketing the company ensures the highest flexibility and a very short time to market. An important factor of success is the continuous optimization of manufacturing costs, which also allows for the unbeatable cost effectiveness. Due to possibilities like potential exclusive agreements the NanoRepro AG is a trading partner with a great deal to offer.